Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTX-microparticles versus cisplatin intrapleural infusion for malignant pleural effusion
ChiCTR-TRC-14004820Phase 2Recruiting
- Sponsor
- Union Hospital of Huazhong University of Science and Technology
- Start
- Jun 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of methotrexate and cisplatin in malignant pleural effusion (MPE) (2 arms), sponsored by Union Hospital of Huazhong University of Science and Technology. Primary endpoint: Pleural effusion volume. Started Jun 2014; status: recruiting.
02
Drugs
methotrexatecisplatin
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on ChiCTR-TRC-14004820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004820.